Carboplatin versus alternating carboplatin and doxorubicin for the adjuvant treatment of canine appendicular osteosarcoma: a randomized, phase III trial

Author:

Skorupski K. A.1,Uhl J. M.2,Szivek A.2,Allstadt Frazier S. D.1,Rebhun R. B.1,Rodriguez C. O.1

Affiliation:

1. Department of Veterinary Surgical and Radiological Sciences; University of California; Davis CA USA

2. Veterinary Medical Teaching Hospital; University of California; Davis CA USA

Publisher

Wiley

Subject

General Veterinary

Reference18 articles.

1. Amputation and cisplatin for the treatment of canine osteosarcoma;Straw;Journal of Veterinary Internal Medicine,1991

2. Treatment of dogs with osteosarcoma by administration of cisplatin after amputation or limb-sparing surgery: 22 cases (1987-1990);Berg;Journal of the American Veterinary Medical Association,1992

3. Amputation and carboplatin for treatment of dogs with osteosarcoma: 48 cases (1991 to 1993);Bergman;Journal of Veterinary Internal Medicine,1996

4. Use of single-agent carboplatin as adjuvant or neoadjuvant therapy in conjunction with amputation for appendicular osteosarcoma in dogs;Phillips;Journal of the American Animal Hospital Association,2009

5. Predictors of outcome in dogs treated with adjuvant carboplatin for appendicular osteosarcoma: 65 cases (1996-2006);Saam;Journal of the American Veterinary Medical Association,2011

Cited by 63 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Metallocompounds as anticancer agents against osteosarcoma;Drug Discovery Today;2024-09

2. Co-delivery of carboplatin and doxorubicin using ZIF-8 coated chitosan-poly(N-isopropyl acrylamide) nanoparticles through a dual pH/thermo responsive strategy to breast cancer cells;International Journal of Biological Macromolecules;2024-06

3. Cancer Immunotherapy;Veterinary Clinics of North America: Small Animal Practice;2023-12

4. Efficacy and toxicity of carboplatin in the treatment of macroscopic mesenchymal neoplasia in dogs;Veterinary and Comparative Oncology;2023-09-13

5. Signal Transduction Inhibitors;Therapeutic Strategies in Veterinary Oncology;2023-08-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3